Reduction in event rates |
-
•
Fear of hospitalization and contracting COVID-19 in the inpatient setting (↓ CV and HF hospitalizations, ↓ myocardial infarctions)
-
•
Hospitalization attributed to COVID-19 (↓ CV and HF hospitalizations, even with concurrent exacerbation)
-
•
Decreased patient physical activity and provoked symptoms (↓ clinical visits and hospitalizations)
|
-
•
Fear of hospitalization, reducing adjudication (↓ CV and HF deaths)
-
•
Sicker patients may reside in skilled nursing facilities with exposure to COVID-19 (↑ COVID-19 deaths with ↓ CV and HF deaths)
-
•
Financial incentive to attribute death to COVID-19 in the United States (↓ CV and HF deaths)
|
|
|
Increase in event rates |
-
•
COVID-19 infection & inflammation increases risk of underlying HF exacerbation (↑ CV and HF events including ↑ myocardial infarctions)
-
•
Increased thrombosis associated with COVID-19 (↑ CV events)
-
•
COVID-19 increases risk of renal injury (↑ renal injury)
|
|
|
-
•
Concern that cardiovascular medications such as angiotensin system antagonists may increase risk for or worsen COVID-19 (↑ CV and HF events and ↑ CV and HF deaths)
-
•
Inability to obtain therapies, including due to cost (due to loss of employment) or fear of contracting COVID-19 (↑ CV events, ↑ outpatient worsening HF events, ↑ CV and HF deaths)
|
Unclear effect on event rates |
|
Increased missing events or events of unknown cause |
|